Table 1.
Baseline characteristics of patients enrolled in hypoglossal nerve stimulation feasibility trials
| Baseline Characteristics |
||||||||
|---|---|---|---|---|---|---|---|---|
| Study | Multi-Center | n | Sex | Age | BMI | AHI | Synchronized Stimulation | Adverse Events* |
| Medtronic | Y | 8 | 8M:0F | 50 (8) | 28 (5) | 52 (20) | Y | 1, 1, 3, 4 |
| Apnex | Y | 21 | 14M:7F | 53 (10) | 32 (4) | 45 (18) | Y | 3, 5 |
| Inspire | Y | 31 | 30M:1F | 53 (12) | 29 (2) | Y | ||
| Phase I | 22 | 22M:0F | 56 (8) | 30 (3) | 44 (18) | 2, 5 | ||
| Phase II | Y | 9 | 8M:1F | 54 (12) | 29 (2) | 40 (10) | 3, 3 | |
| ImThera | N | 14 | 13M:1F | 50 (10) | 31 (4) | 45 (18) | N | 1 |
Values are expressed as means (SD)
*
1, lead failure; 2, infection; 3, device malfunction; 4, sensing problems; 5, miscellaneous.